Please login to the form below

Not currently logged in
Email:
Password:

doxorubicin hydrochloride liposome injection

This page shows the latest doxorubicin hydrochloride liposome injection news and features for those working in and with pharma, biotech and healthcare.

FDA says approval of generic Doxil will ease cancer drug shortage

FDA says approval of generic Doxil will ease cancer drug shortage

The FDA has now approved India-based Sun Pharma's generic version of Doxil (doxorubicin hydrochloride liposome injection), which is protected by orphan drug marketing exclusivity until May 2014, but only ... The FDA also said it expects to stop

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Nucleus Global

Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 700 experts delivering world-class...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics